Joana Bastos

Dr. Joana Bastos

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Chemosphere
Verified
Journal Article
Closed access
NVNicole S. Morgado Vieira
Nicole S. Morgado Vieira
JBJoana Bastos
Joana Bastos
LRLuis Paulo N. Rebelo
Luis Paulo N. Rebelo
AMAna Matias
Ana Matias
João M. M. AraújoJoão M. M. Araújo
João M. M. Araújo
Ana Belén PereiroAna Belén Pereiro
Ana Belén Pereiro

1 July 2019 in Journal of Molecular Liquids
Verified
Journal Article
Closed access
NVNicole S. Morgado Vieira
Nicole S. Morgado Vieira
JBJoana Bastos
Joana Bastos
Carolina Hermida MerinoCarolina Hermida Merino
Carolina Hermida Merino
MPMaría J. Pastoriza-Gallego
María J. Pastoriza-Gallego
LRLuis Paulo N. Rebelo
Luis Paulo N. Rebelo
Ana Belén PereiroAna Belén Pereiro
Ana Belén Pereiro

13 August 2022 in Sustainable Chemistry
Verified
Journal Article
Open access
PDF file
JBJoana Bastos
Joana Bastos
NVNicole S. Morgado Vieira
Nicole S. Morgado Vieira
Maria Manuela GasparMaria Manuela Gaspar
Maria Manuela Gaspar
Ana Belén PereiroAna Belén Pereiro
Ana Belén Pereiro
João M. M. AraújoJoão M. M. Araújo
João M. M. Araújo
Ionic liquids (ILs) are a potential solution to the general problem of low solubility, polymorphism and low bioavailability of active pharmaceutical ingredients (APIs). In this work, we report on the synthesis of three pharmaceutically active ILs (API-ILs) based on ibuprofen, one of the most commonly available over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs), with imidazolium cations ([C2C1Im][Ibu] and [C2(OH)C1Im][Ibu]) and a cholinium cation ([N1112(OH)][Ibu]). An upgrade to the aqueous solubility (water and biological simulated fluids) for the ibuprofen-based ILs relative to the ibuprofen’s neutral and salt form (sodium ibuprofen) was verified. The cytotoxic profiles of the synthesized API-ILs were characterized using two human cells lines, Caco-2 colon carcinoma cells and HepG-2 hepatocellular carcinoma cells, up to ibuprofen’s maximum plasma concentration (Cmax) without impairing their cytotoxicity response. Additionally, the EC50 in the Caco-2 cell line revealed similar results for both parent APIs and API-ILs. The biocompatibility of the ibuprofen-based ILs was also evaluated through a hemolytic activity assay, and the results showed that all the ILs were hemocompatible at concentrations higher than the ibuprofen Cmax. Moreover, the anti-inflammatory properties of the API-ILs were assessed through the inhibition of bovine serum albumin (BSA) denaturation and inhibition of cyclooxygenases (COX-1 and COX-2). The results showed that [C2C1Im][Ibu], [C2(OH)C1Im][Ibu] and [N1112(OH)][Ibu] maintained their anti-inflammatory response to ibuprofen, with improved selectivity towards COX-2, allowing the development of safer NSAIDs and the recognition of new avenues for selective COX-2 inhibitors in cancer chemotherapy and neurological diseases such as Alzheimer’s and Parkinson’s.

16 March 2018 in Chemical Communications
Verified
Journal Article
Open access
PDF file
JBJoana Bastos
Joana Bastos
Sara F. CarvalhoSara F. Carvalho
Sara F. Carvalho
TWTom Welton
Tom Welton
JLJose Nuno Canongia Lopes
Jose Nuno Canongia Lopes
LRLuis Paulo N. Rebelo
Luis Paulo N. Rebelo
Ana Belén PereiroAna Belén Pereiro
Ana Belén Pereiro
We demonstrate that fluorinated ionic liquids reduce the impact of the addition of water upon the ionic liquid's H-bond acceptance ability. This is a key factor to obtain functionalized materials to be used e.g. in the dissolution of biomolecules, extraction processes or material engineering.